Growth Metrics

BridgeBio Pharma (BBIO) Amortizatization of Intangibles (2019 - 2025)

BridgeBio Pharma (BBIO) has disclosed Amortizatization of Intangibles for 7 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • Quarterly Amortizatization of Intangibles rose 47.23% to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.9 million through Dec 2025, up 19.27% year-over-year, with the annual reading at $4.9 million for FY2025, 19.27% up from the prior year.
  • Amortizatization of Intangibles hit $1.5 million in Q4 2025 for BridgeBio Pharma, up from -$49.7 million in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $27.5 million in Q2 2025 to a low of -$49.7 million in Q3 2025.
  • Historically, Amortizatization of Intangibles has averaged $1.4 million across 5 years, with a median of $1.8 million in 2021.
  • Biggest YoY gain for Amortizatization of Intangibles was 1546.58% in 2025; the steepest drop was 8705.5% in 2025.
  • Year by year, Amortizatization of Intangibles stood at $1.8 million in 2021, then grew by 19.92% to $2.1 million in 2022, then tumbled by 228.13% to -$2.7 million in 2023, then surged by 136.81% to $991000.0 in 2024, then skyrocketed by 47.23% to $1.5 million in 2025.
  • Business Quant data shows Amortizatization of Intangibles for BBIO at $1.5 million in Q4 2025, -$49.7 million in Q3 2025, and $27.5 million in Q2 2025.